You may be eligible to participate in the BRAVOS Study if you:

  • Are 18-70 years old
  • Have been diagnosed with diffuse cutaneous systemic sclerosis (dcSSc)
  • Have had dcSSc for 5 or fewer years
  • Have been taking one of the following medications for at least 3 months: methotrexate (Trexall® or Rasuvo®) or mycophenolate mofetil (CellCept®) or azathioprine (Imuran® or Azasan®)

To learn more about this study, visit

BRAVOS is no longer recruiting participants.